Billionaires Holding SRPT

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 41.5M
    Shares Outstanding

  • 1.08B
    Market Cap

News & Insights

ABOUT

SRPT

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. Its lead product candidate is Eteplirsen, an antisense phosphorodiamidate morpholino oligomer therapeutic, which i...

Google parent Alphabet's earnings: $8.42 per share, vs expected EPS of $8.04

NEWS

Amazon keeps its crown as king of cloud as sales pop

READ MORE